Form 4: Vericel Corp Director Steven Gilman Reports Stock Transactions
SEC Form 4
Director Steven Gilman reports exercising stock options and selling shares of Vericel Corp under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On October 16, 2024, Steven Gilman, a director of Vericel Corp, executed transactions involving the company's common stock.
- Gilman exercised options to acquire 5,833 shares at a price of $13.05.
- Simultaneously, Gilman sold 5,833 shares at a price of $41.36.
- Following these transactions, Gilman directly owns 11,000 shares of Vericel Corp.
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 30, 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider trading activity. It is common for executives and directors to have pre-arranged trading plans to avoid accusations of trading on inside information.
Key Dates
| Date | Description |
|---|---|
| May 2, 2018 | Options became exercisable in monthly installments, contingent upon continued service. |
| May 30, 2024 | Adoption date of Rule 10b5-1 trading plan. |
| October 16, 2024 | Date of stock option exercise and sale. |
| October 18, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.